ODE-479

TREATMENT OF PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH SOMATOSTATIN RECEPTOR-POSITIVE GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS), INCLUDING FOREGUT, MIDGUT, AND HINDGUT NEUROENDOCRINE TUMORS